Frontlight ResearchEarly access
Coronary artery disease trials in Canada
36 of 51 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleOCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And Lipoprotein(a) Reduction to Prevent First Major Cardiovascular Events
- Where
- Brampton, Burlington, Calgary, Cambridge, Chicoutimi, Edmonton, Hamilton, London, Mississauga, Montreal, Newmarket, New Westminster, Oakville, Scarborough Village, Surrey, Toronto, Vancouver, Vaughan, Victoria
- Age
- 50 years to 105 years
- People
- 11,000 worldwide
- Run by
- Amgen
See details and how to joinNCT07136012 - Phase 3Taking peopleAspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Controlled Trial
- Where
- Montreal, Québec, Trois-Rivières
- Age
- 40 years and over
- People
- 48
- Run by
- Montreal Heart Institute
See details and how to joinNCT07524335 - Phase 2Taking peopleReversing Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
- Where
- Montreal
- Age
- 40 years and over
- People
- 64
- Run by
- Montreal Heart Institute
See details and how to joinNCT06217120 - Phase 2Not yet taking people in CanadaA Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
- Where
- London, North York, Toronto, Vaughan, Winnipeg
- Age
- 18 years to 80 years
- People
- 456 worldwide
- Run by
- Beijing Inno Medicine Co., Ltd.
See details and how to joinNCT07521007 - Phase 3Not yet taking people in CanadaAspirin for the Prevention of Ischemic Complications in Giant Cell Arteritis
- Where
- Montreal
- Age
- 50 years and over
- People
- 120
- Run by
- Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
See details and how to joinNCT07908082 - No phaseTaking peoplePrevail Global Study
- Where
- Montreal, Ottawa, Toronto, Vancouver
- Age
- 18 years and over
- People
- 1,205 worldwide
- Run by
- Medtronic Vascular
See details and how to joinNCT06535854 - No phaseTaking peopleThe Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
- Where
- Calgary, Edmonton, Halifax, Hamilton, London, Montreal, Newmarket, New Westminster, Ottawa, Québec, Toronto, Vancouver, Winnipeg
- Age
- 18 years and over
- People
- 754 worldwide
- Run by
- Sunnybrook Health Sciences Centre
See details and how to joinNCT05427370 - Phase 4Not yet taking people in CanadaSpontaneous Coronary Artery Dissection - AntipLatelet Therapy Intensity in Guided coNservative Management (SCAD-ALIGN) Trial
- Where
- Vancouver
- Age
- 18 years and over
- People
- 3,518 worldwide
- Run by
- Universitätsklinikum Hamburg-Eppendorf
See details and how to joinNCT07683923 · EU 2025-523985-26-00 - Phase 3Taking peopleLow Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Where
- Calgary, Edmonton, Hamilton, London, Montreal, Oakville, Rimouski, Scarborough Village, St. Catharines, Toronto
- Age
- 18 years and over
- People
- 6,150 worldwide
- Run by
- Population Health Research Institute
See details and how to joinNCT04774159 · EU 2024-512091-35-01 - No phaseTaking peopleExercise Training in Women With Heart Disease 2
- Where
- Ottawa
- Age
- 18 years and over
- People
- 172
- Run by
- Ottawa Heart Institute Research Corporation
See details and how to joinNCT06494163 - No phaseTaking peopleEfficacy of the COronary SInus Reducer in Patients With Refractory Angina II
- Where
- Montreal, Ottawa, Québec, Toronto, Vancouver
- Age
- 18 years and over
- People
- 380 worldwide
- Run by
- Shockwave Medical, Inc.
See details and how to joinNCT05102019 - No phaseNot yet taking people in CanadaHeart tEam Decision-making Assisted by Revaz AI Trial
- Where
- Calgary, Ottawa
- Age
- 18 years and over
- People
- 712
- Run by
- University of Calgary
See details and how to joinNCT07837765 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Edmonton, Halifax, Hamilton, Kingston, London, Longueuil, Montreal, Oshawa, Ottawa, Sherbrooke, Toronto, Vancouver, Winnipeg
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - Phase 3Taking peopleEvaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
- Where
- Edmonton, Hamilton, London, Montreal, Newmarket, Québec
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07102628 - No phaseTaking peopleElectronic Health Record Augmented LDL-Cholesterol Optimization and Control Via Active Lipid Engagement (EHR-LOCALE): A Quality Improvement Implementation Study
- Where
- Edmonton
- People
- 2,000
- Run by
- University of Alberta
See details and how to joinNCT07685639 - Phase 1Taking peopleA Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
- Where
- Chicoutimi, Hamilton, Montreal, Québec, Toronto, Vancouver
- Age
- 18 years to 70 years
- People
- 85 worldwide
- Run by
- Verve Therapeutics, Inc.
See details and how to joinNCT06164730 - No phaseTaking peopleDomain-specific Aerobic Exercise Training in Coronary Artery Disease
- Where
- London
- Age
- 18 years and over
- People
- 105
- Run by
- Western University, Canada
See details and how to joinNCT06143332 - No phaseTaking peopleRandomization of Single vs Multiple Arterial Grafts
- Where
- Hamilton, London, Montreal, Ottawa, Québec, Toronto, Winnipeg
- Age
- 18 years to 70 years
- People
- 4,300 worldwide
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT03217006 - Phase 3Taking peopleEffect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
- Where
- Abbotsford British Columbia, Brampton, Burnaby, Calgary, Cambridge, Chicoutimi, Edmonton, Granby, Greenfield Park, Halifax, Kamloops, Kingston, Laval, Lévis, London, Moncton, Montreal, Newmarket, North Vancouver, Ottawa, Québec, Rimouski, Saint-Charles-Borromée, Saint-Hubert, Saint-Jérôme, Saskatoon, Scarborough Village, Sherbrooke, St. John's, Terrebonne, Toronto, Trois-Rivières, Vancouver, Victoria, Winnipeg
- Age
- 45 years and over
- People
- 2,000 worldwide
- Run by
- DalCor Pharmaceuticals
See details and how to joinNCT05918861 - No phaseTaking peopleImplementing Individualized Patient Reported Outcome Measures in Routine Care of Patients With Coronary Artery Disease
- Where
- Calgary
- Age
- 40 years and over
- People
- 200
- Run by
- University of Calgary
See details and how to joinNCT06164457 - No phaseTaking peopleFeasibility and Pilot Testing of "My Heart and CKD" Online Shared Decision Aid
- Where
- Calgary, Edmonton
- Age
- 18 years and over
- People
- 220
- Run by
- University of Calgary
See details and how to joinNCT06920927 - Phase 2/3Taking peopleCanagliflozin Targeting Vascular Inflammation
- Where
- Ottawa
- Age
- 18 years and over
- People
- 24
- Run by
- Ottawa Heart Institute Research Corporation
See details and how to joinNCT05427084 - No phaseTaking peopleComparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
- Where
- Edmonton, Greater Sudbury, Hamilton, London, Montreal, New Westminster, Ottawa, Saint John, Ste Foy, St. John's, Toronto, Winnipeg
- Age
- 18 years and over
- People
- 2,300 worldwide
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT04124120 - No phaseTaking peopleMiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)
- Where
- Toronto
- Age
- 18 years to 85 years
- People
- 1,300 worldwide
- Run by
- Aristotle University Of Thessaloniki
See details and how to joinNCT05487612 - No phaseTaking peopleCohort Study - SBRT for VT Radioablation
- Where
- Halifax
- People
- 12
- Run by
- John Sapp
See details and how to joinNCT04162171